Debt-to-equity of Rani Therapeutics Holdings, Inc. from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Rani Therapeutics Holdings, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 30 Sep 2025.
Rani Therapeutics Holdings, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -764%, a 236% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Rani Therapeutics Holdings, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	-764%	-1326%	-236%	30 Sep 2025
Q2 2025	-3593%	-3950%	-1106%	30 Jun 2025
Q1 2025	2833%	+2603%	+1132%	31 Mar 2025
Q4 2024	965%	+803%	+495%	31 Dec 2024
Q3 2024	562%	+434%	+339%	30 Sep 2024
Q2 2024	357%	+263%	+280%	30 Jun 2024
Q1 2024	230%	+169%	+277%	31 Mar 2024
Q4 2023	162%	+126%	+343%	31 Dec 2023
Q3 2023	128%	+110%	+606%	30 Sep 2023
Q2 2023	94%	+85%	+930%	30 Jun 2023
Q1 2023	61%			31 Mar 2023
Q4 2022	37%			31 Dec 2022
Q3 2022	18%			30 Sep 2022
Q2 2022	9%			30 Jun 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.